Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR2 | O60603 | 2/20 | 0.33 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.31 |
| ▸ | P2RY10 | O00398 | 1/20 | 0.30 |
| ▸ | GPR174 | Q9BXC1 | 1/20 | 0.30 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24462473 | 0.83 | CTSD (0.45) | TLR2GABRR1ALDH1A1LMNAASAH1 | |
| SCHEMBL22814737 | 0.81 | ALDH1A1 (0.39) | TLR2GABRR1ALDH1A1LMNAASAH1 | |
| SCHEMBL22123634 | 0.79 | MMP2 (0.46) | TLR2GABRR1ALDH1A1LMNAASAH1 | |
| SCHEMBL13351409 | 0.77 | FAAH (0.56) | TLR2ASAH1FAAHDNM1P2RY10 | |
| SCHEMBL22821244 | 0.77 | ALDH1A1 (0.32) | GABRR1ALDH1A1LMNAMMP2 | |
| SCHEMBL22123760 | 0.74 | MMP2 (0.42) | GABRR1LMNAMMP2 | |
| SCHEMBL16985031 | 0.74 | GABRR1 (0.34) | GABRR1ALDH1A1LMNAMMP2 | |
| SCHEMBL16984997 | 0.73 | TERT (0.37) | TLR2ASAH1FAAHDNM1P2RY10 | |
| SCHEMBL1174781 | 0.73 | MEN1 (0.41) | ALDH1A1LMNAFAAHTDP1DNM1 | |
| SCHEMBL16984927 | 0.73 | GABRR1 (0.33) | GABRR1LMNAMMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024146902-A1 | METHODS OF PRODUCING HYDROGEL MICROSPHERES | ASCENDIS PHARMA A/S (DK) | 2024-07-11 | — | — | WO | disclosed |
| WO-2024146920-A1 | DRUG CONJUGATES FOR THE TREATMENT OF OCULAR DISORDERS | ASCENDIS PHARMA OPHTHALMOLOGY DIVISION A/S (DK) | 2024-07-11 | — | — | WO | disclosed |